ERNA

← Markets

ERNAErnexa Therapeutics Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 27
8:01 AMglobenewswire.comErnexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
Fri, Jul 24
8:20 AMYahooErnexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
Wed, Jul 15
8:43 AMinvestorshub.advfn.comErnexa Therapeutics shares soar 30% after independent study validates cancer therapy (ERNA)
6:50 AMYahooErnexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry
Tue, Jul 14
8:01 AMYahooErnexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
Thu, Jun 25
8:15 AMYahooErnexa Therapeutics Launches CEO Corner to Provide Deeper Insights into Company Progress, Scientific Strategy and Vision for Patients
Wed, Jun 17
7:47 AMYahooErnexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study
Tue, Jun 9
7:41 AMYahooErnexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
Wed, May 27
7:11 AMYahooErnexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development
Wed, May 20
9:45 AMYahooERNA Stock Shoots Up 140% in a Month: Here's What You Should Know
7:31 AMYahooErnexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
Mon, May 11
8:15 AMYahooErnexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101